In a Phase 2 study in pediatric insomnia disorder, in addition to marked improvements in sleep measures, daridorexant 50 mg showed an unexpected pattern of improvement in affect and behavior, ...

Ad hoc announcement pursuant to Art. 53 LR In a Phase 2 study in pediatric insomnia disorder, in addition to marked improvements in sleep measures, daridorexant 50 mg showed an unexpected pattern of ...

By Dennis Thompson HealthDay ReporterMONDAY, Oct. 26, 2026 (HealthDay News) — Nearly 1 in 5 young adults in the U.S. feel ...

Emotion recognition in psychosis predicts violence risk, a Karolinska Institutet study in Schizophrenia finds. Patients with ...

Prognica Labs, a Dubai-headquartered AI-driven life sciences company, and Pinnacology Research & Development, an India-based ...

Anxiety and depression increased among LGBTQ+ youth over a two-year period, even as rates of self-harm and suicide attempts ...

Hello, I am 'Murabito,' a physical therapist.While working as a physical therapist (PT), I share 'lifestyle tips' that help ...

Researchers from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC will lead a worldwide effort to map how eight common psychiatric ...

This case demonstrates an unusual manifestation of late-life anxiety in which voluntary physical restraint functioned as a ...

A 36-participant pilot randomized trial will assess the feasibility of in-person UCLA PEERS in Italian routine care and ...

Katie Fraser Allen explores a study on autism, ADHD and AuDHD in eating disorder services that are often overlooked in this ...

GLP-1 receptor agonists affect pathways involved in mood, appetite, and reward, prompting research into their potential ...